Results 11 to 20 of about 28,276 (143)
Rhabdomyolysis is a serious but rare side effect of Lamivudine treatment. Therefore, appropriate biochemical monitoring should be undertaken when it is used in the treatment of hepatitis B.
Janudin Baharin +2 more
doaj +1 more source
Top-Down Synthesis of a Lamivudine-Zidovudine Nano Co-Crystal
Lamivudine (3TC) and zidovudine (AZT) are antiretroviral agents used to manage HIV/AIDS infection. A wet media milling top-down approach was used to develop and produce nano co-crystals of 3TC and AZT.
Bwalya A. Witika +2 more
doaj +1 more source
Inflammatory Biomarkers Decay After First-Line Antiretroviral Therapy Initiation With Dolutegravir/Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide in Persons With HIV: A Substudy of a Randomized Clinical Trial. [PDF]
Health Science Reports, Volume 9, Issue 3, March 2026.
Fernandez A +6 more
europepmc +2 more sources
QUANTITATION OF LAMIVUDINE BY UV SPECTROPHOTOMETRY
HIV infection poses a threat to the existence of humankind as a whole. Currently, lamivudine is widely used in antiretroviral therapy regimens. Modern methods of assessing quality, both in substance and in tablets, are characterized by a number of ...
Y. A. Gonchikova +2 more
doaj +1 more source
Five-year results of oral antiviral therapy in HBeAg-negative chronic Hepatitis B
Background/Aims: Several guidelines recommend the use of tenofovir or entecavir as the first-line treatment for hepatitis B due to the lower resistance rates of these drugs than lamivudine, although lamivudine may still be preferred because of its low ...
Kadri Atay +9 more
doaj +1 more source
A novel, simple, precise and accurate method developed for the estimation of Lamivudine and tenofovir disoproxil fumarate (TDF) in bulk drug form has been established. Lamivudine and tenofovir are well known drugs and used in treatment of HIV- Ⅰ.
Shweta Sharma +3 more
doaj +1 more source
Background Lamivudine inhibits replication of both human immunodeficiency virus (HIV) and hepatitis B virus (HBV) and is commonly used as part of antiretroviral therapy. The main limitation in the use of lamivudine is resistant mutation selection.
Arabe Juçara +3 more
doaj +1 more source
Experience with lamivudine treatment for severe acute hepatitis B [PDF]
Introduction. Experience with lamivudine treatment for acute severe hepatitis B is limited. Fulminant hepatitis develops in 1% of immunocompetent patients with acute hepatitis B. Objective.
Verhaz Antonija
doaj +1 more source
LIVER TRANSPLANTATION AND HBV INFECTION
The paper describes the modern approaches in treatment of hepatitis B virus (HBV)-infected patients who underwent liver transplantation. The patients with HBV liver cirrhosis and waiting for orthotopic liver transplantation (OLT) have to receive long ...
O. I. Andreytseva +2 more
doaj +1 more source

